Targeted cancer therapies

Article ID	Journal	Published Year	Pages	File Type
8698357	The Journal of the American Dental Association	2018	12 Pages	PDF

Abstract

In this narrative review, the authors focus mainly on the orofacial adverse effects of targeted cancer therapies and outline many of the agents that are in use so the dentally focused reader can familiarize themselves with these adverse effects and agents.

Keywords

mAbs FDA MRONJ HNSCC TKI EGFR PD-1 HER2 Bisphosphonates Biologics Food and Drug Administration Non–small-cell lung cancer NSCLC Vascular endothelial growth factor Vascular Endothelial Growth Factor (VEGF)programmed cell death 1 Tyrosine kinase inhibitor Small molecules Small molecule Monoclonal antibodies Head and neck squamous cell carcinoma Human epidermal growth factor receptor 2 Epidermal growth factor receptor

Related Topics

Health Sciences Medicine and Dentistry Dentistry, Oral Surgery and Medicine

Preview

Authors

Eleni PhD, MD, DDS, MSc, Justin FRCP, BM, BCh, MA (Oxon), FRCP, PhD, Crispian CBE, DSc, DChD, DMed(HC), MD, PhD, FMedSci, MDS, MRCS, FDSRCS, FDSRCPS, FFDRCSI, FDSRCSE, FRCPath, FHEA,